31 results
8-K
EX-99.1
VTRO
Vitro Biopharma, Inc.
22 Jan 24
Vitro Biopharma Announces New Chief Financial Officer
9:17pm
developmental delays including autistic features, language delays, intellectual disability, neuro-irritability and significant behavioral concerns. We currently
8-K
EX-10.2
VTRO
Vitro Biopharma, Inc.
22 Jan 24
Vitro Biopharma Announces New Chief Financial Officer
9:17pm
not experienced any illness, injury, or disability compensable or recoverable under the worker’s compensation laws of any state, and Haas agrees that he … will not file a worker’s compensation claim asserting the existence of any such illness, injury, or disability. Haas understands and agrees
10-12G/A
9nv1pll
21 Dec 22
Registration of securities (amended)
4:50pm
10-12G/A
99yrfj0pna qld
4 Nov 22
Registration of securities (amended)
3:29pm
S-1/A
0hbq4jor3bdhx2b
3 Nov 22
IPO registration (amended)
5:28pm
10-12G
EX-99.1
4yka0op0r aqlzpgxolq
9 Sep 22
Registration of securities
9:46pm
S-1
EX-10.18
5o9yld6abpjj
9 Sep 22
IPO registration
5:13pm
S-1
EX-10.4
03y64 m6x
9 Sep 22
IPO registration
5:13pm
S-1
EX-10.19
f38ms8j ov3
9 Sep 22
IPO registration
5:13pm
S-1
EX-10.20
rmkj0kci3 3e1unk
9 Sep 22
IPO registration
5:13pm
S-1
EX-10.8
pjcwsn
9 Sep 22
IPO registration
5:13pm